A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects

MLA

Takashi K. Ito, et al. “A Single Oral Supplementation of Nicotinamide within the Daily Tolerable Upper Level Increases Blood NAD+ Levels in Healthy Subjects.” Translational Medicine of Aging, vol. 5, no. 43–51, Jan. 2021, pp. 43–51. EBSCOhost, https://doi.org/10.1016/j.tma.2021.09.001.

APA

Takashi K. Ito, Tomohito Sato, Yusuke Takanashi, Zinat Tamannaa, Takuya Kitamoto, Keiichi Odagiri, & Mitsutoshi Setou. (2021). A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects. Translational Medicine of Aging, 5(43–51), 43–51. https://doi.org/10.1016/j.tma.2021.09.001

Chicago

Takashi K. Ito, Tomohito Sato, Yusuke Takanashi, Zinat Tamannaa, Takuya Kitamoto, Keiichi Odagiri, and Mitsutoshi Setou. 2021. “A Single Oral Supplementation of Nicotinamide within the Daily Tolerable Upper Level Increases Blood NAD+ Levels in Healthy Subjects.” Translational Medicine of Aging 5 (43–51): 43–51. doi:10.1016/j.tma.2021.09.001.